Tag: analyst

Latest News

Defying analyst expectations, Eisai launches study of a-beta drug BAN 2401 in Alzheimer’s

After Thursday’s halt to aducanumab’s development dealt a significant blow to the amyloid beta hypothesis in Alzheimer’s, analysts had expected BAN 2401 – developed under...

Managing Partner of KICVentures and Former J.P. Morgan Analyst Predicts Continued Valuation Growth in the Spine Device Market

BOSTON (PRWEB) November 13, 2018 Aditya Humad, Managing Partner of KICVentures , released an analysis of the spine technology market last week that asserts it...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World